Research any topic before you write.

Find related topics. | Discover entities. | See connections. | Build a topical map.

Rilonacept

Rilonacept, sold under the brand name Arcalyst, is a medication used to treat cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome, and Muckle–Wells syndrome; deficiency of interleukin-1 receptor antagonist; and recurrent pericarditis. Rilonacept is an interleukin 1 inhibitor.

Overview, Related Topics & Entities

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Research this topic

Explore the main themes, entities and connections around Rilonacept. Start with the topic map, then use the sections below for research and deeper semantic analysis.

Explore this topic

Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

AHFS/Drugs.com
Monograph
ATC code
L04AC04 (WHO)
CAS Number
501081-76-1 Y
ChEMBL
ChEMBL1201830 N
ChemSpider
none
DrugBank
DB06372 Y

Topics to explore

Browse the full topic structure. Each item opens a new analysis centered on that subject.

Overview

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

Map overview Semantic statistics

Rilonacept

Nodes14
Edges13
Triples24
Avg. degree1.86
Density0.142857
Components1

How this topic connects Entity context

See the strongest relationship patterns around the current topic before diving into the raw triples.

Rilonacept

Top relations

related to External links · 5
Rilonacept → Archived, Drug Information Portal, January, Medicine, National Library
Legal status · 2
Rilonacept → EU: Rx-only, US: ℞-only
License data · 2
Rilonacept → EU EMA: by INN, US DailyMed: Rilonacept
is a · 2
Rilonacept → first drug approved by the FDA to treat recurrent pericarditis, interleukin 1 inhibitor.Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellular portions of the human interleukin-1 receptor component
AHFS/Drugs.com · 1
Rilonacept → Monograph
ATC code · 1
Rilonacept → L04AC04 (WHO)
CAS Number · 1
Rilonacept → 501081-76-1 Y
ChEMBL · 1
Rilonacept → ChEMBL1201830 N
ChemSpider · 1
Rilonacept → none
DrugBank · 1
Rilonacept → DB06372 Y

Important terminology Word statistics

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

drug fda pericarditis used treat cryopyrin-associated periodic syndromes including familial cold autoinflammatory syndrome muckle wells interleukin-1 receptor recurrent treatment approved

Entity relationships Subject–Predicate–Object triples

SubjectPredicateObjectConfidenceSrc
RilonaceptAHFS/Drugs.comMonograph1.00infobox
RilonaceptATC codeL04AC04 (WHO)1.00infobox
RilonaceptCAS Number501081-76-1 Y1.00infobox
RilonaceptChEMBLChEMBL1201830 N1.00infobox
RilonaceptChemSpidernone1.00infobox
RilonaceptDrugBankDB06372 Y1.00infobox
RilonaceptFormulaC9030H13932N2400O2670S741.00infobox
RilonaceptKEGGD066351.00infobox
RilonaceptLegal statusUS: ℞-only1.00infobox
RilonaceptLegal statusEU: Rx-only1.00infobox
RilonaceptLicense dataEU EMA: by INN1.00infobox
RilonaceptLicense dataUS DailyMed: Rilonacept1.00infobox
RilonaceptMolar mass201209.36 g·mol−11.00infobox
RilonaceptOther namesIL-1 Trap1.00infobox
RilonaceptRoutes of administrationSubcutaneous1.00infobox
RilonaceptTrade namesArcalyst1.00infobox
RilonaceptUNII8K80YB5GMG1.00infobox
Rilonaceptis ainterleukin 1 inhibitor.Rilonacept is a dimeric fusion protein consisting of the ligand-binding domains of the extracellular portions of the human interleukin-1 receptor component0.90text
Rilonaceptis afirst drug approved by the FDA to treat recurrent pericarditis0.90text

Related concept clusters Concept neighborhoods

These clusters group vocabulary that occurs around closely connected concepts in the source material.

    Connections between topic areas Semantic bridges

    Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.

    Min side: 3
    For writers, content strategists, SEOs, marketers and creators — from quick topic research to advanced semantic analysis.